# A Clinical Study of iNSC Intervent Cerebral Hemorrhagic Stroke

> **NCT03725865** · EARLY_PHASE1 · UNKNOWN · sponsor: **Allife Medical Science and Technology Co., Ltd.** · enrollment: 12 (estimated)

## Conditions studied

- Stroke, Ischemic

## Interventions

- **BIOLOGICAL:** Induction of neural stem cells

## Key facts

- **NCT ID:** NCT03725865
- **Lead sponsor:** Allife Medical Science and Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03
- **Primary completion:** 2019-03
- **Final completion:** 2019-03
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2018-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03725865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03725865, "A Clinical Study of iNSC Intervent Cerebral Hemorrhagic Stroke". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03725865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*